Editas Medicine (EDIT) Change in Account Payables (2015 - 2025)

Editas Medicine (EDIT) has reported Change in Account Payables for 11 consecutive years, with -$3.6 million the latest figure, recorded in Q3 2025.

• In Q3 2025, Change in Account Payables fell 183.97% year-over-year to -$3.6 million; the TTM figure through Sep 2025 stood at -$9.3 million (down 540.25% YoY), while the FY2024 annual figure was -$2.3 million, down 53.22% from the prior year.
• Change in Account Payables slipped to -$3.6 million in Q3 2025 per EDIT's latest filing, from $1.3 million in the prior quarter.
• Across five years, Change in Account Payables topped out at $7.4 million in Q2 2024 and bottomed at -$7.0 million in Q4 2024.
• Historically, Change in Account Payables has averaged -$151526.3 across 5 years, with a median of -$229000.0 in 2022.
• Annual changes were most pronounced in 2023 — Change in Account Payables sank 196.29% — and 2024, when it soared 1161.95%.
• Editas Medicine's Change in Account Payables stood at $1.8 million in 2021, then soared by 46.49% to $2.7 million in 2022, then tumbled by 196.29% to -$2.6 million in 2023, then plunged by 169.81% to -$7.0 million in 2024, then soared by 49.12% to -$3.6 million in 2025.
• Business Quant data shows EDIT's Change in Account Payables at -$3.6 million in Q3 2025, $1.3 million in Q2 2025, and -$27000.0 in Q1 2025.